Sagent gets approval for generic bladder inflammation treatment Matrix Labs' Videx EC generic approved by FDA FDA approves expanded use of Tarceva Gilead commences phase 3 trial for single-tablet HIV treatment Strativa gets FDA approval for opharyngeal candidiasis drug Merck KGaA's investigational MS drug may improve patients' condition Novo Nordisk seeks to uncover psychological, social effects of hemophilia Impax completes enrollment for late-stage trial for Parkinson's disease drug Study: Remicade more efficient in treating Crohn's disease than generic competitor Pfizer Oncology to present cancer drugs at annual cancer research conference First Previous 199 200 201 202 203 Next Last